drugset / Trial / NCT02742857

Non-randomized, Open-labeled, Interventional, Single Group, Proof of Concept Study With Multi-modality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury

NCT02742857

NaSingle-groupOpen-labelOther

Summary

This is the proof of concept study with multi-modality approach (using intra-thecal bioactive peptides, stem cells, laser and transcranial IV laser and Median Nerve stimulation as adjuvants) in cases of brain death due to traumatic brain injury having diffuse axonal injury to document possibility of reversal of brain death (BD).

Timeline

Start
2016-07
Primary completion
2020-08
Completion
2020-08

Drugs

EvaluationDrugModalityDoseRoute
Subject BQ-A Peptide Extract Peptide Intrathecal
Subject mesenchymal stem cells Cell therapy

Indications

No indication recorded.